Michael F. Mahoney - 04 Oct 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Chairman, President & CEO, Director
Signature
/s/ Vance R. Brown, Attorney-in-fact
Issuer symbol
BSX
Transactions as of
04 Oct 2021
Net transactions value
-$7,293,175
Form type
4
Filing time
05 Oct 2021, 16:32:00 UTC
Previous filing
08 Sep 2021
Next filing
02 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $847,725 +134,988 +6.5% $6.28* 2,216,810 04 Oct 2021 Direct F1
transaction BSX Common Stock Options Exercise $488,139 +66,054 +3% $7.39* 2,282,864 04 Oct 2021 Direct F1
transaction BSX Common Stock Sale $4,151,110 -97,838 -4.3% $42.43 2,185,026 04 Oct 2021 Direct F2, F3
transaction BSX Common Stock Sale $4,477,929 -103,204 -4.7% $43.39 2,081,822 04 Oct 2021 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -134,988 -50% $0.000000 134,988 04 Oct 2021 Common Stock 134,988 $6.28 Direct F1, F5
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -66,054 -14% $0.000000 396,322 04 Oct 2021 Common Stock 66,054 $7.39 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F3 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.02 to $43.01, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.68, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F6 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.